23andMe: Current personal genomics market leader turned market loser?
Pivotal decision to not invest in new genetic technology to undercut 23andMe’s future position in the consumer genomics space
Pivotal decision to not invest in new genetic technology to undercut 23andMe’s future position in the consumer genomics space